Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12. - Wikidata - awgldk - TriplyDB

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12.

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12.

http://www.wikidata.org/entity/Q36145716

about

Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C.Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting.Identification of Predictors for Treatment Failure in Hepatitis C Virus Patients Treated With Ledipasvir and Sofosbuvir.Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents.Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs.Adverse effects of direct acting antiviral-based regimens in chronic hepatitis C patients: a Brazilian experience.Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens.Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.

P2860

Q30393824-9438A6B0-FD62-46F2-910B-36F369ADA033 Q33805907-72ED9E32-3158-4174-AE30-1C09AAE74C8A Q40338014-968E7735-962D-4B5F-977C-29073F84DCFC Q42719904-DA93C41F-098C-40AE-A015-EDAD2EE035D9 Q47121746-4BB830FB-8AA5-40CE-A7F3-1C2C8E329706 Q48110717-DDF3C312-7002-435A-877F-78F5C87DAF5A Q49200882-5688607A-5219-443E-AA2C-3229791FD9DF Q55027157-A7FEE35A-BAC4-4255-85CB-F2981AF148E9

P2860

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12.

http://www.wikidata.org/entity/Q36145716

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Second-generation direct-actin ...... fety, and predictors of SVR12.

@ast

Second-generation direct-actin ...... fety, and predictors of SVR12.

@en

type

label

Second-generation direct-actin ...... fety, and predictors of SVR12.

@ast

Second-generation direct-actin ...... fety, and predictors of SVR12.

@en

prefLabel

Second-generation direct-actin ...... fety, and predictors of SVR12.

@ast

Second-generation direct-actin ...... fety, and predictors of SVR12.

@en

P1433

Q36145716-05179A04-6DEC-43FF-A8DD-60FD57F559D0

P1476

Q36145716-C15673E2-7169-465C-979C-6D01556A9ACF

P2093

Q36145716-41EA2F55-707D-42FC-8021-7F9F19CE3EC4

Q36145716-5C9DB3EC-318D-4673-921A-5C30AC1A9907

Q36145716-ADFA2854-98C7-453E-81D3-B9C21F3B6CAE

Q36145716-B58AAB2B-14FB-432F-800D-520377BD5F52

Q36145716-F80722B5-E23A-4030-A676-A941D14B6086

Q36145716-FB4A76C2-3F4B-4BF6-898C-ED39FD0B732E

P2860

Q36145716-092954FE-FFF6-4F18-A58D-935A1ECCF6B9

Q36145716-10A6CAA1-B34D-4A35-9C66-7C403D02D09E

Q36145716-11E0E3E7-69EE-4DE9-8AFB-F36D0B993B18

Q36145716-1983389B-CC0E-411D-8509-C770EFFA38AF

Q36145716-207BC75E-7E07-4703-B364-9E1DB3881555

Q36145716-448CC6F8-8089-4766-9DF9-1EA42EE352B2

Q36145716-4CF39B5E-99E6-42AA-B33C-18450E72D20B

Q36145716-5160A181-625A-4D98-ACA1-EBC513B8B15B

Q36145716-5DB6182C-E98E-4C7A-B2CF-928F969C17F6

Q36145716-693748DE-900E-47E0-9E89-0E1499DDB98F

P304

Q36145716-6746EA1A-5B35-42AC-9DC5-FC82E985AB96

P31

Q36145716-831FE3F1-B48E-414F-974D-13A95AEF8112

P356

Q36145716-DD80DBF2-AC72-44C6-B681-E30984F15F62

P407

Q36145716-A1B185EB-6A78-490B-873E-6788D69DDD52

P433

Q36145716-AB9876B6-1EB8-4BC0-B2DE-153D402FFECB

P478

Q36145716-1937F1AE-C7C9-4A6D-A875-B3DAEF52D67F

P50

Q36145716-F491983F-9262-43F9-8F8F-D42C46CB4150

P577

Q36145716-FAE69C05-11C8-4740-9316-FC2CF35EC795

P698

Q36145716-500A2550-31B0-4DDC-A7E1-B42C992C0023

P932

Q36145716-9E947003-CBCA-4367-888B-F03BD2C56C66

P356

WJG.V22.I35.8050

P1433

World Journal of Gastroenterology

P1476

Second-generation direct-actin ...... fety, and predictors of SVR12.

@en

P2093

Christoph P Berg

http://www.w3.org/2001/XMLSchema#string

Daniel P Egetemeyr

http://www.w3.org/2001/XMLSchema#string

Julia M Schwarz

http://www.w3.org/2001/XMLSchema#string

Nisar P Malek

http://www.w3.org/2001/XMLSchema#string

Robert Beck

http://www.w3.org/2001/XMLSchema#string

Ulrich M Lauer

http://www.w3.org/2001/XMLSchema#string

P2860

Boceprevir for previously treated chronic HCV genotype 1 infection

Global epidemiology and genotype distribution of the hepatitis C virus infection

Global epidemiology of hepatitis C virus infection

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Telaprevir for retreatment of HCV infection

Telaprevir for previously untreated chronic hepatitis C virus infection

Sofosbuvir for previously untreated chronic hepatitis C infection

The global burden of hepatitis C

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

P304

8050-8059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V22.I35.8050

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Christoph R. Werner

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27672299

http://www.w3.org/2001/XMLSchema#string

P932

5028818

http://www.w3.org/2001/XMLSchema#string